Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Runze Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of anti-infective medications, particularly cephalosporin antibiotics. The company operates significant production facilities for both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, including sterile powders for injection and oral preparations. Its product portfolio features widely used antibiotics such as Ceftriaxone Sodium, Cefotaxime Sodium, and Cefazolin Sodium. Shandong Runze Pharmaceutical serves both domestic and international markets, maintaining compliance with Good Manufacturing Practice (GMP) standards to ensure high-quality chemical synthesis and pharmaceutical production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Runze Pharmaceutical.